Your cart is currently empty!
Site Map
- Accreditations & Certifications
- APEX PROGRAM
- Careers
- History
- Partnerships
- Success Stories
- Client Portals
- NAMSA Acquires AKRN
- NAMSA Acquires American Preclinical Services
- NAMSA Acquires Medanex
- NAMSA Acquires Perfectus
- NAMSA Acquires SUAZIO
- NAMSA Acquires Syntactx
- NAMSA Leadership Team
- Therapeutic Devices
- Cardiovascular Devices
- Dental Devices
- Diabetes Care Devices
- Gastroenterology Devices
- IVD Devices
- Neurovascular Devices
- Ophthalmology Devices
- Cardiovascular Device Expertise
- Peripheral Vascular Devices
- General Surgery Devices
- Wound Care Devices
- EXPE-C001 – Team
- Clinical Services
- Clinical Study Design
- Clinical Trial Management
- Clinical Data Management
- Biostatistics Consulting
- Medical Writing
- FSP Outsourcing
- Consulting Services
- EU MDR & IVDR Consulting
- US FDA Consulting
- FDA 510(k) Consultants
- FDA De Novo Submissions
- Investigational Device Exemptions (FDA IDE) for Medical Devices
- FDA PMA Consulting
- FDA Pre-Submission and Q-Sub Submission Consulting for Medical Devices
- Global Consulting
- Global RA/QA Consulting
- Borderline and Combination Products
- QMS Implementation
- Medical Device Clinical and Regulatory Strategy Roadmap Consulting
- Animal Tissue Device Support
- AI and Medical Device Software Regulatory Support
- Market Research
- Biological Safety Consulting
- Preclinical Research
- Medical Device Testing
